Quick Answer
Lantern Pharma Inc. reported Total Assets of $11.04 million for fiscal year 2025.
Lantern Pharma Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $11.04M | -56.8% |
| 2024 | $25.57M | -41.4% |
| 2023 | $43.65M | -25.8% |
| 2022 | $58.84M | -20.4% |
| 2021 | $73.95M | +263.2% |
| 2020 | $20.36M | +1321.2% |
| 2019 | $1.43M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $13.63M | -55.0% | -21.8% |
| June 30, 2025 | $17.42M | -51.0% | -17.4% |
| March 31, 2025 | $21.10M | -46.9% | -17.5% |
| December 31, 2024 | $25.57M | -41.4% | -15.6% |
| September 30, 2024 | $30.29M | -36.6% | -14.9% |
| June 30, 2024 | $35.59M | -30.8% | -10.4% |
| March 31, 2024 | $39.73M | -28.4% | -9.0% |
| December 31, 2023 | $43.65M | -25.8% | -8.6% |
- Lantern Pharma Inc. showed a decrease of -56.8% in Total Assets compared to the prior fiscal year.
- Over the 2019–2025 period, Lantern Pharma Inc.’s total assets has grown by 670.3% (from $1.43 million to $11.04 million).
- The most recent figure is from Lantern Pharma Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 30, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: